Novel FGF9 variant contributes to multiple synostoses syndrome 3

A novel heterozygous variant in FGF9 associated with previously unreported features of multiple synostosis syndrome 3

(2020) Ann‐Charlotte Thuresson et al.   CLINICAL GENETICS

The role of the fibroblast growth factor family in bone‐related diseases

(2019) Jicheng Wang et al.   Chemical Biology & Drug Design

Multiplex targeted high‐throughput sequencing in a series of 352 patients with congenital limb malformations

(2019) Anne‐Sophie Jourdain et al.   HUMAN MUTATION

A point mutation in Fgf9 impedes joint interzone formation leading to multiple synostoses syndrome

(2017) Lingyun Tang et al.   HUMAN MOLECULAR GENETICS

Regulation of Receptor Binding Specificity of FGF9 by an Autoinhibitory Homodimerization

(2017) Yang Liu et al.   STRUCTURE

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

(2015) Sue Richards et al.   GENETICS IN MEDICINE

A New Subtype of Multiple Synostoses Syndrome Is Caused by a Mutation inGDF6That Decreases Its Sensitivity to Noggin and Enhances Its Potency as a BMP Signal

(2015) Jian Wang et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effect of fibroblast growth factor 9 on the osteogenic differentiation of bone marrow stromal stem cells and dental pulp stem cells

(2014) JINGTING LU et al.   Molecular Medicine Reports

Multiple Synostoses Syndrome Is Due to a Missense Mutation in Exon 2 of FGF9 Gene

(2009) Xiao-lin Wu et al.   AMERICAN JOURNAL OF HUMAN GENETICS

FGF9 monomer–dimer equilibrium regulates extracellular matrix affinity and tissue diffusion

(2009) Masayo Harada et al.   NATURE GENETICS